CAS: 183321-74-6 - Erlotinib
Formula:C22H23N3O4
InChI:InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)
InChI key:InChIKey=AAKJLRGGTJKAMG-UHFFFAOYSA-N
SMILES:C#CC1=CC=CC(=C1)NC=2N=CN=C3C=C(OCCOC)C(OCCOC)=CC32
- Synonyms:
- 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-
- 4-[(3-Ethynylphenyl)Amino]-6,7-Bis(2-Methoxyethoxy)Quinazoline
- Erlotinib & its intermediates (Developing)
- Erlotinib Base
- Erlotinin
- N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine
- N-(3-Ethynylphenyl)[6,7-Bis(2-Methoxyethoxy)Quinazolin-4-Yl]Amine
- NSC 718781
- Osi 744
- R 1415
- See more synonyms
- Erlotinib
Ref: 41-Y0002444
150mg | 228.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-
CAS:183321-74-6
Formula:
C22H23N3O4
Purity:
95%
Color and Shape:
Solid
Molecular weight:
393.4357
Ref: IN-DA0027HY
1g | 34.00 € | ||
5g | 72.00 € | ||
10g | 108.00 € | ||
25g | 182.00 € | ||
100g | 549.00 € | ||
100mg | 27.00 € | ||
250mg | 31.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Erlotinib
CAS:183321-74-6
Erlotinib (NSC-718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment …
Formula:
C22H23N3O4
Purity:
98.19% - 99.98%
Color and Shape:
White To Off-White Powder
Molecular weight:
393.44
Ref: TM-T0373
50mg | 47.00 € | ||
100mg | 52.00 € | ||
500mg | 78.00 € | ||
1mL*10mM (DMSO) | 55.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Erlotinib
CAS:183321-74-6
Formula:
C22H23N3O4
Purity:
≥ 99.0% (anhydrous basis)
Color and Shape:
White to light-yellow powder
Molecular weight:
393.44
Ref: 7W-GP0576
1g | 165.00 € |
Estimated delivery in United States, on Wednesday 8 Jan 2025
Erlotinib Free Base
CAS:183321-74-6
Formula:
C22H23N3O4
Purity:
By hplc: >99% (Typical Value in Batch COA)
Color and Shape:
white solid
Molecular weight:
393.44g/mol
Ref: 54-BIFK0019
1g | 158.00 € | ||
500mg | 103.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine
Controlled ProductCAS:183321-74-6
Applications Erlotinib is a EGFR-targeted drug in the treatment of non-small cell lung cancer. EGFR …
Formula:
C22H23N3O4
Color and Shape:
Neat
Molecular weight:
393.44
Ref: TR-E625008
1g | 140.00 € | ||
25g | 658.00 € | ||
500mg | 91.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025
Erlotinib base
CAS:183321-74-6
Tyrosine kinase inhibitor; affects EGFR receptor; pancreatic cancer treatment
Formula:
C22H23N3O4
Purity:
Min. 99 Area-%
Color and Shape:
Powder
Molecular weight:
393.44 g/mol
Ref: 3D-BE164419
100mg | 137.00 € |
Estimated delivery in United States, on Thursday 30 Jan 2025